Top compounds associated with response to U2AF1


Feature Type Standardized
Nominal ANOVA
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA ZSTK474 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.018 0.7
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.02 0.7
mRNA Erlotinib gCSI pan-cancer AAC 0.023 0.7
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.016 0.7
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.016 0.7
Download CSV